Table 1

Polycythemias studied

DiagnosisGene mutationsNumber of patientsSensitivity of erythroid colonies to EPO
Primary polycythemias PV JAK2V617F mutation n = 6 Hypersensitive and EPO independent 
PFCP EPORQ434X mutation* n = 2 Hypersensitive and EPO independent 
EPOR5967insT mutation n = 2 Hypersensitive and EPO independent 
Polycythemias with features of primary and secondary polycythemia Congenital polycythemias due to VHL mutations VHLR200W mutation10  (Chuvash polycythemia) n = 2 Hypersensitive 
VHLP138L mutation16  n = 1 Hypersensitive 
VHLT124A/L188V mutation17  n = 2 Hypersensitive 
Congenital polycythemias due to HIF2A mutation HIF2AM353V mutation18  n = 1 Hypersensitive 
HIF2AG537R mutation18  n = 1 Hypersensitive 
Congenital polycythemia LNKI257T mutation n = 1 Hypersensitive 
Secondary polycythemias Congenital polycythemia due to VHL mutation VHLH191D mutation19  (Croatian type) n = 2 Normal 
Secondary polycythemia due to hypoxia Low pO2 n = 6 Normal 
DiagnosisGene mutationsNumber of patientsSensitivity of erythroid colonies to EPO
Primary polycythemias PV JAK2V617F mutation n = 6 Hypersensitive and EPO independent 
PFCP EPORQ434X mutation* n = 2 Hypersensitive and EPO independent 
EPOR5967insT mutation n = 2 Hypersensitive and EPO independent 
Polycythemias with features of primary and secondary polycythemia Congenital polycythemias due to VHL mutations VHLR200W mutation10  (Chuvash polycythemia) n = 2 Hypersensitive 
VHLP138L mutation16  n = 1 Hypersensitive 
VHLT124A/L188V mutation17  n = 2 Hypersensitive 
Congenital polycythemias due to HIF2A mutation HIF2AM353V mutation18  n = 1 Hypersensitive 
HIF2AG537R mutation18  n = 1 Hypersensitive 
Congenital polycythemia LNKI257T mutation n = 1 Hypersensitive 
Secondary polycythemias Congenital polycythemia due to VHL mutation VHLH191D mutation19  (Croatian type) n = 2 Normal 
Secondary polycythemia due to hypoxia Low pO2 n = 6 Normal 
*

Two previously unreported subjects of European descent with PFCP due to the EPOR gain-of-function EPORQ434X mutation; this mutation was previously reported in a Japanese family.14 

Two Czech patients whose phenotype was previously described.15 

A patient with no detectable EPOR, JAK2V617F, or JAK2 exon 12 mutations and low level of EPO (<1 mU/mL) who was heterozygous for a single-nucleotide polymorphism in exon 3 (rs147341899) in the LNK gene.

or Create an Account

Close Modal
Close Modal